FindTrial
Sign In

Alteration of Gut Microbiota in Patients with Advanced Hepatocellular carcinoma

Alteration of Gut Microbiota in Patients with Advanced Hepatocellular carcinoma: A Cross-sectional Analytical Study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20230908007
Enrollment
60
Registered
2023-09-08
Start date
2023-09-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Hepatocellular carcinoma HCC

Interventions

Advanced HCC patients,Healthy population
Basic Science,Basic Science
HCC,Healthy population

Sponsors

Faculty of Medicine, Khon Kaen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged more than 18 years old diagnosed with advanced hepatocellular carcinoma. 2. No other concomittent malignancy, or cured for more than 5 years. 3. Born in the northeastern part of Thailand

Exclusion criteria

Exclusion criteria: 1. Patients who diagnosed with Hepatocellular cholangiocarcinoma 2. Current users of drug/substanced affected to gut microbiota or history of use within 14 days e.g. antibiotics , proton pump inhibitor, probiotics product, Ursodeoxycholic Acid 3. Have specific eating pattern 4. Cannot obtain fecal sample or not enough sample for analysis

Design outcomes

Primary

MeasureTime frame
Gut microbiota differenceby genus/family Cross sectional study Mean difference—

Secondary

MeasureTime frame
6-month survival Sixth month Time (month)—

Countries

Thailand

Contacts

Public ContactThanakorn Charoenthanadhol

Khon Kaen University

modthanakorn@hotmail.com0908949515

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026